VENTANA ALK (D5F3) CDx Assay

ALK (D5F3) Assay and Detection with Amplification vs. FISH

Technical benefits of IHC testing

ALK FISH can present technical challenges in evaluating patient results and offers the potential for false negatives. Recent studies indicate that the ALK (D5F3) Assay stained with OptiView DAB Detection and Amplification (OptiView DAB Detection and Amp) is sensitive and specific for determination of ALK status, and a better alternative to ALK FISH. There are reports of ALK IHC-positive, FISH-negative patients benefitting from treatment with XALKORI or ZYKADIA.1, 2, 3

Figure 1. Comparison of ALK (D5F3) Assay stained with OptiView DAB Detection and Amp vs. FISH testing for ALK mutation

  ALK (D5F3) Assay with OptiView DAB Detection and Amp ALK FISH
Easy to score
  • Binary (+/-) scoring
  • Any strong positive staining in any number of cells is positive for ALK
  • Requires a dual color scoring algorithm
  • Requires 50 enumerable cells and specific cutoff ratios to be calculated
Faster turnaround times
  • 4 hours, fully automated
  • Routine IHC testing
  • 12+ hours, semi-automated
  • Typically batch or send-out testing
Bright field vs.
flourescent staining
  • Standard brightfield microscope
  • Fully archivable results
  • Full visibility of tumor morphology
  • Requires a flourescent microscope
  • Staining and signal fade over time
  • Loss of tissue morphology
REFERENCES:

1. Zhou J, Zhao J, Sun K, Wang B, Wang L, et al. Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening. PLoS ONE (2014) 9(3): e92828. doi:10.1371/journal.pone.0092828.


2. Ling Shan, Fang Lian, Lei Guo, Xin Yang, Jianming Ying and Dongmei Lin. Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement. Diagnostic Pathology 2014, 9:3. doi:10.1186/1746-1596-9-3.


3. Ying, J.; Guo, L.; Qiu, T.; Shan, L.; Ling, Y.; Liu, X.; Lu, N. Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma. Annals of Oncology. 24(10):2589-2593, October 2 Modern Pathology (2013) 26, 1545–1553; doi:10.1038/modpathol.2013.87; published online 7 June 2013.

 

Online training for pathologists – US

Provided through Roche Diagnostics University
To access training after clicking this link:

  1. Create or sign in to your account as prompted
  2. Enter “VENTANA ALK (D5F3) CDX Assay” in the Search field, top right

Related Links

> Product Catalog
> MSDS/SDS
> Search by disease state
> Package Inserts
> Interpretation Guide
> XALKORI.com
> ZYKADIA.com